Register and login to access premium content
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.
UroToday International Journal connects global clinicians from the urology community to one of the most extensive online urological disease collections. We focus on fast-tracked information, providing original studies and case reports within months of acceptance so our urologic community can stay up-to-date on emerging evidence that supports clinical practice decisions towards improving patient outcomes.
We provide patient education, CME programs, clinical trial recruitment services, and various articles from around the globe to our over 30,000 subscribers via the computer or mobile device, making our content both current and accessible. On top of our content provided by professional urologists from all over the globe, our editorial board is comprised of leaders in urology across the globe.
For our authors, we provide open access and do not charge for the submission process, editorial review, and publication in UIJ. It is our goal to provide positive support to our authors, as well as an efficient platform to publish their case studies, reviews, and original research.
The editor in chief assigns papers considered for publication to the associate editor who communicates with the author and expert reviewers. A statistician analyzes any statistics included. Other experts may be invited to comment where appropriate. Similar procedures may be used for other contributions to the journal. All manuscripts are subject to copy editing and formatting to conform to UIJ standards.
If a manuscript is sent for revision to an author, whether major or minor, the revised manuscript must be returned within 30 days. If it is not received at the editorial office within this timeframe, it is treated as a new submission and sent out for review to different reviewers.